AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 288: R903-R908, 2005. First published December 16, 2004; doi:10.1152/ajpregu.00530.2004
0363-6119/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/4/R903    most recent
00530.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yanes, L.
Right arrow Articles by Reckelhoff, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yanes, L.
Right arrow Articles by Reckelhoff, J. F.

NEUROHUMORAL CONTROL OF CARDIOVASCULAR FUNCTION

Systemic arterial pressure response to two weeks of Tempol therapy in SHR: involvement of NO, the RAS, and oxidative stress

Licy Yanes,1 Damian Romero,2 Radu Iliescu,1 Valeria E. Cucchiarelli,1 Lourdes A. Fortepiani,1 Francisco Santacruz,3 William Bell,1 Huimin Zhang,1 and Jane F. Reckelhoff1

Departments of 1Physiology and Biophysics and 2Medicine, University of Mississippi Medical Center, Jackson, Mississippi; and 3Department of Physiopathology, University of Medicine, Asuncion, Paraguay

Submitted 5 August 2004 ; accepted in final form 15 December 2004

The roles of nitric oxide (NO) and plasma renin activity (PRA) in the depressor response to chronic administration of Tempol in spontaneously hypertensive rats (SHR) are not clear. The present study was done to determine the effect of 2 wk of Tempol treatment on blood pressure [mean arterial pressure (MAP)], oxidative stress, and PRA in the presence or absence of chronic NO synthase inhibition. SHR were divided into four groups: control, Tempol (1 mmol/l) alone, nitro-L-arginine methyl ester (L-NAME, 4.5 mg·kg–1·day–1) alone, and Tempol + L-NAME for 2 wk. With Tempol, MAP decreased by 22%: 191 ± 3 and 162 ± 21 mmHg for control and Tempol, respectively (P < 0.05). L-NAME increased MAP by 16% (222 ± 2 mmHg, P < 0.01), and L-NAME + Tempol abolished the depressor response to Tempol (215 ± 3 mmHg, P < 0.01). PRA was not affected by Tempol but was increased slightly with L-NAME alone and 4.4-fold with L-NAME + Tempol. Urinary nitrate/nitrite increased with Tempol and decreased with L-NAME and L-NAME + Tempol. Tempol significantly reduced oxidative stress in the presence and absence of L-NAME. In conclusion, in SHR, Tempol administration for 2 wk reduces oxidative stress in the presence or absence of NO, but in the absence of NO, Tempol is unable to reduce MAP. Therefore, NO, but not changes in PRA, plays a major role in the blood pressure-lowering effects of Tempol. These data suggest that, in hypertensive individuals with endothelial damage and chronic NO deficiency, antioxidants may be able to reduce oxidative stress but not blood pressure.

nitric oxide; superoxide; antioxidant; renin-angiotensin system



Address for reprint requests and other correspondence: J. F. Reckelhoff, Dept. of Physiology and Biophysics, Univ. of Mississippi Medical Center, 2500 N. State St., Jackson, MS 39216-4505 (E-mail: jreckelhoff{at}physiology.umsmed.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. J. Miller, L. E. Norton, M. P. Murphy, M. C. Dalsing, and J. L. Unthank
The role of the renin-angiotensin system and oxidative stress in spontaneously hypertensive rat mesenteric collateral growth impairment
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2523 - H2531.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. Vera, S. Kelsen, L. L. Yanes, J. F. Reckelhoff, and D. E. Stec
HO-1 induction lowers blood pressure and superoxide production in the renal medulla of angiotensin II hypertensive mice
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1472 - R1478.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. Schluter, R. Grimm, A. Steinbach, G. Lorenz, R. Rettig, and O. Grisk
Neonatal sympathectomy reduces NADPH oxidase activity and vascular resistance in spontaneously hypertensive rat kidneys
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R391 - R399.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. T. de Richelieu, C. M. Sorensen, N.-H. Holstein-Rathlou, and M. Salomonsson
NO-independent mechanism mediates tempol-induced renal vasodilation in SHR
Am J Physiol Renal Physiol, December 1, 2005; 289(6): F1227 - F1234.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.